142 related articles for article (PubMed ID: 21775886)
1. Monotherapy versus fortified antibiotics for bacterial keratitis.
Rosenberg JB; Gritz DC
Cornea; 2011 Sep; 30(9):1066; author reply 1066-7. PubMed ID: 21775886
[No Abstract] [Full Text] [Related]
2. Randomized clinical study for comparative evaluation of fourth-generation fluoroquinolones with the combination of fortified antibiotics in the treatment of bacterial corneal ulcers.
Shah VM; Tandon R; Satpathy G; Nayak N; Chawla B; Agarwal T; Sharma N; Titiyal JS; Vajpayee RB
Cornea; 2010 Jul; 29(7):751-7. PubMed ID: 20489580
[TBL] [Abstract][Full Text] [Related]
3. Fluoroquinolones in corneal ulcers.
Galvis V; Tello A; Guerra AR; Acuña MF; Villarreal D
Ophthalmology; 2013 Sep; 120(9):e61-2. PubMed ID: 24001539
[No Abstract] [Full Text] [Related]
4. Author reply: To PMID 23415776.
Sharma N; Goel M; Bansal S; Agarwal P; Titiyal J; Upadhyaya A; Vajpayee R
Ophthalmology; 2013 Sep; 120(9):e62. PubMed ID: 24001541
[No Abstract] [Full Text] [Related]
5. Moxifloxacin for bacterial keratitis.
Rosenberg J; Eisen L; Kim J
Ophthalmology; 2008 Jun; 115(6):1103; author reply 1103. PubMed ID: 18519075
[No Abstract] [Full Text] [Related]
6. Evaluation of moxifloxacin 0.5% in treatment of nonperforated bacterial corneal ulcers: a randomized controlled trial.
Sharma N; Goel M; Bansal S; Agarwal P; Titiyal JS; Upadhyaya AD; Vajpayee RB
Ophthalmology; 2013 Jun; 120(6):1173-8. PubMed ID: 23415776
[TBL] [Abstract][Full Text] [Related]
7. Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
Bashir H; Dave A; Mathur U
Cornea; 2016 Aug; 35(8):e22-3. PubMed ID: 27227400
[No Abstract] [Full Text] [Related]
8. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
[TBL] [Abstract][Full Text] [Related]
10. Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.
Lee SB; Oliver KM; Strube YN; Mohan SK; Slomovic AR
Can J Ophthalmol; 2005 Dec; 40(6):750-3. PubMed ID: 16391641
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
Hyndiuk RA; Eiferman RA; Caldwell DR; Rosenwasser GO; Santos CI; Katz HR; Badrinath SS; Reddy MK; Adenis JP; Klauss V
Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
[TBL] [Abstract][Full Text] [Related]
12. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
Panda A; Ahuja R; Sastry SS
Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis.
Baker RS; Flowers CW; Casey R; Fong DS; Wilson MR
Arch Ophthalmol; 1996 May; 114(5):632-3. PubMed ID: 8619784
[No Abstract] [Full Text] [Related]
14. Visual recovery in treated bacterial keratitis.
Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; Ray KJ; Zegans ME; Acharya NR; Lietman TM; Keenan JD;
Ophthalmology; 2014 Jun; 121(6):1310-1. PubMed ID: 24612976
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers.
Gangopadhyay N; Daniell M; Weih L; Taylor HR
Br J Ophthalmol; 2000 Apr; 84(4):378-84. PubMed ID: 10729294
[TBL] [Abstract][Full Text] [Related]
16. Fourth-generation fluoroquinolone-resistant bacterial keratitis.
Jhanji V; Sharma N; Satpathy G; Titiyal J
J Cataract Refract Surg; 2007 Aug; 33(8):1488-9. PubMed ID: 17662450
[TBL] [Abstract][Full Text] [Related]
17. The increasing problem of antibiotic resistance.
Mamalis N
J Cataract Refract Surg; 2007 Nov; 33(11):1831-2. PubMed ID: 17964369
[No Abstract] [Full Text] [Related]
18. In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
Kowalski RP; Kowalski TA; Shanks RM; Romanowski EG; Karenchak LM; Mah FS
Cornea; 2013 Jun; 32(6):830-4. PubMed ID: 23132444
[TBL] [Abstract][Full Text] [Related]
19. Methicillin-Resistant Staphylococcus aureus Keratitis: Initial Treatment, Risk Factors, Clinical Features, and Treatment Outcomes.
Durrani AF; Atta S; Bhat AK; Mammen A; Dhaliwal D; Kowalski RP; Jhanji V
Am J Ophthalmol; 2020 Jun; 214():119-126. PubMed ID: 32209347
[TBL] [Abstract][Full Text] [Related]
20. Topical antibiotics for the management of bacterial keratitis: an evidence-based review of high quality randomised controlled trials.
McDonald EM; Ram FS; Patel DV; McGhee CN
Br J Ophthalmol; 2014 Nov; 98(11):1470-7. PubMed ID: 24729078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
